Abstract
Aims: Endothelin-1 (ET-1), a key mediator of inflammatory processes associated with gastric mucosal injury, is a potent vasoactive peptide produced from a biologically inactive big ET-1 by the action of endothelin-converting enzyme-1 (ECE-1). In this study, we investigated gastric mucosal expression of ECE-1 during a 16 h course of inflammatory responses associated with gastric mucosal damage caused by indomethacin, and evaluated the effect of pretreatment with an antiulcer agent, sucralfate, on this process. ___TAGSTART___BR___TAGEND___Methods: The experiments were conducted with groups of rats pretreated intragastrically with sucralfate at 200 mg/kg or vehicle, followed 30 min later by an intragastric dose of indomethacin at 60 mg/kg, and at different time (2, 4, 8, and 16 h) intervals, their stomachs were used for macroscopic and biochemical assessments. ___TAGSTART___BR___TAGEND___Results: Examination of gastric mucosa from the control animals revealed that, within 2 h, indomethacin caused multiple hemorrhaging lesions, the extent of which reached a maximum after 4 h and was accompanied by a 4-fold enhancement in the expression of ECE-1 activity, and a marked elevation in ET-1 (4.5-fold), TNF-α (11.3-fold) and apoptosis (29.9-fold). Pretreatment with sucralfate produced within 2 h a 59.7% reduction in the extent of mucosal damage caused by indomethacin, while an 81% reduction in lesion was observed after 16 h. This effect of sucralfate was accompanied by a significant reduction in the mucosal expression of ECE-1, the activity of which declined by 57.3% within 2 h following sucralfate, while a 38.4% decline in the indomethacin-induced expression of ECE-1 was attained after 16 h. Moreover, the reduction in the severity of damage following pretreatment with sucralfate was reflected at the end of 16-h period in a 47.4% decrease in the mucosal expression of TNF-α, 25.1% decline in ET-1, and a 38.9% decline in apoptosis. ___TAGSTART___BR___TAGEND___Conclusions: The results demonstrate that gastric mucosal injury by indomethacin is associated with up-regulation of ECE-1 expression, which leads to the enhancement of ET-1 production, induction of TNF-α, and triggering of apoptotic events that exacerbate the inflammatory process. Our findings also show that sucralfate protection against gastric mucosal injury caused by indomethacin involves the suppression of the mucosal ECE-1 activity.
This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Bianchi Porro, G. and Santalucia, F. (1995). Sucralfate for NSAID-induced gastroduodenal lesions, in: Sucralfate from basic science to the bedside, D. Hollander and G. N. J. Tytgat (Eds), pp. 277–288. Plenum Medical, New York.
Boros, M., Massberg, S., Baranyi, L., et al. (1998). Endothelin-1 induces leukocyte adhesion in submucosal venules of the rat small intestine, Gastroenterology 114, 103–114.
Carter, S. R., Slomiany, A., Gwozdzinski, K., et al. (1988). Effect of ethanol on mucus glycoprotein sulfotransferase from gastric mucosa, J. Biol. Chem. 263, 11977–11984.
Eaker, E. Y. (1997). Gastrointestinal injury related to use of nonsteroidal anti-inflammatory drugs, Gastrointestinal Dis. Today 6,1–8.
Ehrenreich, H., Loffler, B. M., Hasselblatt, M., et al. (1999). Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors, Biochem. Biophys. Res. Commun. 261, 149–155.
Fiorucci, S., Antonelli, E., Santucci, L., et al. (1999). Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats, Gastroenterology 116, 1089–1106.
Gallois, C., Habib, A., Tao, J., et al. (1998). Role of NFκB in the antiproliferative effects of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells, J. Biol. Chem. 273, 23183–23190.
Hassan, M., Kashimura, H., Matsumaru, K., et al. (1997). Gastric mucosal injury induced by local ischemia-reperfusion in rats: role of endogenous endothelin-1 and free radicals, Dig. Dis. Sci. 42, 1375–1380.
Higuchi, H. and Satoh, T. (1997). Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ET(B) receptors in isolated perfused rat liver, Eur. J. Pharmac. 328, 175–182.
Hunt, R. J. (1991). The treatment of peptic ulcer disease with sucralfate: a review, Am. J. Med. 91 (Suppl. 2A), 102S–106S.
Inoue, A., Yanagisawa, M., Takuwa, Y., et al. (1989). The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc. Natl. Acad. Sci. USA 86, 2863–2867.
Konturek, S. J., Konturek, J. W., Brzozowski, T., et al. (1995). Effects of sucralfate on growth factor availability, in: Sucralfate from basic science to the bedside, D. Hollander and G. N. J. Tytgat (Eds), pp. 175–179. Plenum Medical, New York.
Lam, S. K. (1995). Therapy of gastric ulcer disease, in: Sucralfate from basic science to the bedside, D. Hollander and G. N. J. Tytgat (Eds), pp. 239–247. Plenum Medical, New York.
Masuda, E., Kawano, S., Nagano, K., et al. (1993). Role of endogenous endothelin in the pathogenesis of ethanol-induced gastric mucosal injury in rats, Am. J. Physiol. 265, G474–481.
Matsumaru, K., Kashimura, H., Hassan, M., et al. (1997). Phosphoramidon, an inhibitor of endothelin-converting enzyme, prevents indomethacin-induced gastric mucosal damage, Gastroenterology 112, A214.
Matsuura, A., Kawashima, S., Yamochi, W., et al. (1997). Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells, Biochem. Biophys. Res. Commun. 235, 713–716.
McCarthy, D. M. (1995). Mechanism of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs, Scand. J. Gastroenterol. 30 (Suppl. 208), 24–29.
Michida, T., Kawano, S., Masuda, E., et al. (1997). Endothelin-1 in the gastric mucosa in stress ulcers of critically ill patients, Am. J. Gastroenterol. 92, 1177–1181.
Okazawa, M., Shiraki, T., Ninomiya, H., et al. (1998). Endothelin-induced apoptosis of A375 human melanoma cells, J. Biol. Chem. 273, 12584–12592.
Pollock, D. M., Keith, T. L. and Highsmith, R. F. (1995). Endothelin receptors and calcium signaling, FAS EB J. 9, 1196–1204.
Ruetten, H. and Thiemermann, C. (1997). Endothelin-1 stimulates the biosynthesis of tumor necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone, J. Physiol. Pharmacol. 48, 675–688.
Shao, R. S., Yan, W. and Rockey, D. C. (1999). Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing, J. Biol. Chem. 274, 3228–3234.
Shigematsu, T., Miura, S., Hirokawa, M., et al. (1998). Endothelins promote egg albumin-induced intestinal anaphylaxis in rats, Gastroenterology 115, 348–356.
Slomiany, A., Mizuta, K., Piotrowski, J., et al. (1990). Gastric mucosal protection by sucralfate involves phosphoinositides participation, Int. J. Biochem. 22, 1179–1183.
Slomiany, B. L., Murty, V. L. N., Piotrowski, E., et al. (1994). Activation of arachidonoyl phospholi-pase A2 in prostaglandin-mediated action of sucralfate, Gen. Pharmacol. 25, 261–266.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1997a). Induction of tumor necrosis factor-α and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine, Scand. J. Gastroenterol. 32, 638–642.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1997b). Cell cycle progression during ulcer healing by ebrotidine and sucralfate, Gen. Pharmac. 29, 367–370.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1998). Effect of sulglycotide on the apoptotic processes associated with indomethacin-induced gastric mucosal injury, Inflammopharmacol. 6, 243–253.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1999a). Role of caspase-3 and nitric oxide syntase-2 in gastric mucosal injury induced by indomethacin: effect of sucralfate, J. Physiol. Pharmacol. 50, 3–16.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1999b). Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: effect of antiulcer agents, Scand. J. Gastroenterol. 34, 459–464.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1999c). Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents, J. Physiol. Pharmacol. 50, 197–210.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (1999d). Downregulation of endothelin-1 by interleukin-4 during gastric ulcer healing, Biochem. Biophys. Res. Commun. 263, 591–595.
Slomiany, B. L. and Slomiany, A. (2000). Induction of endothelin-converting enzyme-1 in gastric mucosal injury by indomethacin, Biochem. Biophys. Res. Commun. 269, 377–381.
Slomiany, B. L., Piotrowski, J. and Slomiany, A. (2000). Up-regulation of endothelin-converting enzyme-1 in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide, Biochem. Biophys. Res. Commun. 267, 801–805.
Takeuchi, K., Tekehara, K. and Ohuchi, T. (1996). Diethyldithiocarbamate, a superoxide dismutase inhibitor, reduces indomethacin-induced gastric lesions in rats, Digestion 57, 201–209.
Wallace, J. L., McKnight, W., Miyasaka, M., et al. (1993). Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury, Am. J. Physiol. 265, G993–998.
Waisman, Y., Zahavi, I., Marcus, H., et al. (1988). Sucralfate is protective against indomethacin-induced intestinal ulceration in the rat, Digestion 41, 78–82.
Xin, X., Cai, Y., Matsumoto, K., et al. (1995). Endothelin-induced interleukin-6 production by rat aortic endothelial cells, Endocrinology 136, 132–137.
Xu, D., Emoto, N., Giaid, A., et al. (1994). ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1, Cell 78, 473–485.
Rights and permissions
About this article
Cite this article
Slomiany, B.L., Slomiany, A. Suppression of endothelin-converting enzyme-1 by sucralfate, a factor in gastric mucosal resistance to indomethacin injury in rats. Inflammopharmacology 8, 207–218 (2000). https://doi.org/10.1163/15685600038233
Issue Date:
DOI: https://doi.org/10.1163/15685600038233